PDCD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.394300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.512000E-02
Normal-vs-Stage2
5.519500E-02
Normal-vs-Stage3
5.662000E-02
Normal-vs-Stage4
2.395000E-01
Stage1-vs-Stage2
9.046200E-01
Stage1-vs-Stage3
3.035400E-01
Stage1-vs-Stage4
5.727400E-01
Stage2-vs-Stage3
2.175000E-01
Stage2-vs-Stage4
4.643000E-01
Stage3-vs-Stage4
2.080000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.832400E-02
Normal-vs-AfricanAmerican
4.376400E-01
Normal-vs-Asian
1.398010E-01
Caucasian-vs-AfricanAmerican
1.659430E-01
Caucasian-vs-Asian
9.141200E-01
AfricanAmerican-vs-Asian
3.646400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.884100E-02
Normal-vs-Female
7.065900E-02
Male-vs-Female
9.198000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.145900E-02
Normal-vs-Age(41-60Yrs)
6.312500E-02
Normal-vs-Age(61-80Yrs)
5.014400E-02
Normal-vs-Age(81-100Yrs)
2.405200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.528200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.027000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.168400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.636400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.506000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.457410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.897990E-02
Normal-vs-Daily Drinker
1.592420E-02
Normal-vs-Weekly Drinker
9.272100E-02
Normal-vs-Occasional Drinker
5.209700E-02
Normal-vs-Social Drinker
1.047230E-01
Non Drinker-vs-Daily Drinker
6.159800E-01
Non Drinker-vs-Weekly Drinker
5.992600E-01
Non Drinker-vs-Occasional Drinker
5.698000E-01
Non Drinker-vs-Social Drinker
2.642200E-01
Daily Drinker-vs-Weekly Drinker
3.884000E-01
Daily Drinker-vs-Occasional Drinker
3.400000E-01
Daily Drinker-vs-Social Drinker
1.534230E-01
Weekly Drinker-vs-Occasional Drinker
9.824200E-01
Weekly Drinker-vs-Social Drinker
6.630600E-01
Occasional Drinker-vs-Social Drinker
6.032200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.830200E-02
Normal-vs-Grade 2
2.474100E-02
Normal-vs-Grade 3
3.030100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.873600E-01
Grade 1-vs-Grade 3
4.810000E-01
Grade 1-vs-Grade 4
6.830200E-02
Grade 2-vs-Grade 3
9.787600E-01
Grade 2-vs-Grade 4
2.474100E-02
Grade 3-vs-Grade 4
3.030100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.248500E-02
Normal-vs-NonDiabetic
3.696400E-02
Diabetic-vs-NonDiabetic
2.752000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.778400E-03
Normal-vs-NoPancreatitis
4.140100E-02
Pancreatitis-vs-NoPancreatitis
6.320400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.041000E-01
Normal-vs-N1
4.239500E-02
N0-vs-N1
2.623800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.244240E-01
Normal-vs-TP53-NonMutant
3.757800E-01
TP53-Mutant-vs-TP53-NonMutant
1.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
